4D Molecular Therapeutics, Inc. (FDMT)
10.93
+0.10
(+0.92%)
USD |
NASDAQ |
Dec 11, 16:00
10.93
0.00 (0.00%)
After-Hours: 18:13
4D Molecular Therapeutics Cash from Investing (Quarterly): 17.78M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aura Biosciences, Inc. | -44.02M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
| Oragenics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -46.50M |
| Cash from Financing (Quarterly) | 0.116M |
| Free Cash Flow | -185.05M |
| Free Cash Flow Per Share (Quarterly) | -0.8268 |
| Free Cash Flow to Equity (Quarterly) | -45.59M |
| Free Cash Flow to Firm (Quarterly) | -46.41M |
| Free Cash Flow Yield | -31.71% |